Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00003958
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:29.432176+00:00
Published At
2013-06-17T00:00:00+00:00
Record Updated At
2013-06-17
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Malignant Mesenchymoma", "Adult Rhabdomyosarcoma", "Alveolar Childhood Rhabdomyosarcoma", "Childhood Malignant Mesenchymoma", "Embryonal Childhood Rhabdomyosarcoma", "Embryonal-botryoid Childhood Rhabdomyosarcoma", "Nonmetastatic Childhood Soft Tissue Sarcoma", "Previously Untreated Childhood Rhabdomyosarcoma", "Stage I Adult Soft Tissue Sarcoma", "Stage II Adult Soft Tissue Sarcoma", "Stage III Adult Soft Tissue Sarcoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-06-17"
protocolSection.identificationModule.nctId
"NCT00003958"
protocolSection.identificationModule.officialTitle
"Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Adult Malignant Mesenchymoma (protocolSection.conditionsModule.conditions)
  • Adult Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Alveolar Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Childhood Malignant Mesenchymoma (protocolSection.conditionsModule.conditions)
  • Embryonal Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Embryonal-botryoid Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Nonmetastatic Childhood Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Previously Untreated Childhood Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Stage I Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage II Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.